Splenosis imaging with 99mTc nano-colloid as a different mimicker in a lymphoma patient on 18F- FDG PET/CT; [Scintigraphie aux nanocolloïdes-33mTc pour différencier une splénose d'un ganglion lymphatique fixant le 18F-FDG]
| dc.contributor.author | Sezgin C. | |
| dc.contributor.author | Parlak Y. | |
| dc.contributor.author | Mutevelizade G. | |
| dc.contributor.author | Gumuser G. | |
| dc.contributor.author | Sayit E. | |
| dc.date.accessioned | 2025-04-10T11:02:26Z | |
| dc.date.available | 2025-04-10T11:02:26Z | |
| dc.date.issued | 2024 | |
| dc.description.abstract | Fluorodeoxyglucose (FDG) 18F-FDG PET/CT plays an important role in lymphoma staging and evaluation of treatment response. Mimics should be considered when evaluating 18F-FDG PET/CT images to perform correct staging and correct treatment response evaluation. Splenosis is one of the causes that may cause misinterpretation by mixing with lymph nodes in lymphoma patients. In our case report, we visualized splenosis mimicking lymph node in a 50-year-old lymphoma patient with 99mTc nano-colloid scintigraphy. © 2024 Elsevier Masson SAS | |
| dc.identifier.DOI-ID | 10.1016/j.mednuc.2024.02.002 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14701/44062 | |
| dc.publisher | Elsevier Masson s.r.l. | |
| dc.title | Splenosis imaging with 99mTc nano-colloid as a different mimicker in a lymphoma patient on 18F- FDG PET/CT; [Scintigraphie aux nanocolloïdes-33mTc pour différencier une splénose d'un ganglion lymphatique fixant le 18F-FDG] | |
| dc.type | Article |